Instil Bio, Inc. Board of Directors

Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Dr. Mark E. Dudley Ph.D.

Dr. Mark E. Dudley Ph.D.

Chief Scientific Officer

Dr. Sandeep Laumas M.D.

Dr. Sandeep Laumas M.D.

CFO & Chief Business Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.